| 摘要 |
<p>Disclosed is a pharmaceutical composition for combating beta-lactamase mediated antibiotic resistance, said pharmaceutical composition comprising a beta-lactam antibiotic, wherein said beta-lactam antibiotic is ceftriaxone or a pharmaceutically acceptable salt thereof, which is ceftriaxone sodium;a beta-lactamase inhibitor, wherein said beta-lactamase inhibitor is sulbactam or a pharmaceutically acceptable salt thereof, which is sulbactam sodium; wherein said beta-lactam antibiotic and said beta-lactamase inhibitors are present in a weight ratios of 1:4 to 4:1 along with EDTA or a pharmaceutically acceptable salt thereof.</p> |
